> [Original Message] > From: Andreas Ramos <andreas@xxxxxxxxxxx> > To: Lit-Ideas <lit-ideas@xxxxxxxxxxxxx> > Date: 6/18/2006 10:43:05 PM > Subject: [lit-ideas] Genentech tries to block effective medicine in order to profit > > > > Prof Rosenfeld said the real issue was drug company profits. "This truly is a wonder drug," > he said. "This shows both how good they [the drug companies] are and on the flip side, how > greedy they are." He would like to see governments fund clinical trials of drugs such as > Avastin in the public interest. > Except usually they're not good. Occasional breakthroughs like this make it look like these companies are researching away. They're not. Mostly they 'research' the same blockbuster pills over and over to keep patent licensing active. Then along comes something like Avastin and they keep it off the market also for the money. If this isn't misanthropy in action, what is it? I thought this was interesting: http://today.reuters.com/news/globalcoverage.aspx?type=smallarms&src=061906_ 1013_FEATURES_global_small_arms_trade ------------------------------------------------------------------ To change your Lit-Ideas settings (subscribe/unsub, vacation on/off, digest on/off), visit www.andreas.com/faq-lit-ideas.html